ALLMedicine™ Blepharitis Center
Research & Reviews 366 results
http://emedicine.medscape.com/article/2014952-overview
Jan 23rd, 2023 - Specific Organisms and Therapeutic Regimens Blepharitis is a common chronic inflammation of the eyelid margin found in all ethnicities, genders, and age groups, though more common in those over the age of 50. [1] Clinically, there is irritation of...
https://emedicine.medscape.com/article/2014952-print
Jan 23rd, 2023 - Blepharitis is a common chronic inflammation of the eyelid margin found in all ethnicities, genders, and age groups, though more common in those over the age of 50.[1] Clinically, there is irritation of the eyelid margins as well as flaking/crusti...
https://emedicine.medscape.com/article/2014952-overview
Jan 23rd, 2023 - Specific Organisms and Therapeutic Regimens Blepharitis is a common chronic inflammation of the eyelid margin found in all ethnicities, genders, and age groups, though more common in those over the age of 50. [1] Clinically, there is irritation of...
https://www.ncbi.nlm.nih.gov/books/n/gene/dkc/
Jan 19th, 2023 - Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals ...
https://clinicaltrials.gov/ct2/show/NCT03926026
Jan 19th, 2023 - This is a multi-center, randomized, double-masked, placebo-controlled, Phase 2 study evaluating the safety and tolerability of NCX 4251 (fluticasone propionate nanocrystal) Ophthalmic Suspension 0.1% QD and BID for the treatment of acute exacerbat...
Guidelines 1 results
https://doi.org/10.1016/j.ophtha.2018.10.019
Ophthalmology Amescua G, Akpek EK et. al.
Oct 28th, 2018 - Blepharitis Preferred Practice Pattern®.|2018|Amescua G,Akpek EK,Farid M,Garcia-Ferrer FJ,Lin A,|organization & administration,therapeutic use,diagnosis,drug therapy,diagnosis,therapeutic use,pathology,organization & administration,standards,stand...
Drugs 90 results see all →
Clinicaltrials.gov 64 results
https://clinicaltrials.gov/ct2/show/NCT03926026
Jan 19th, 2023 - This is a multi-center, randomized, double-masked, placebo-controlled, Phase 2 study evaluating the safety and tolerability of NCX 4251 (fluticasone propionate nanocrystal) Ophthalmic Suspension 0.1% QD and BID for the treatment of acute exacerbat...
https://clinicaltrials.gov/ct2/show/NCT04675242
Dec 14th, 2022 - This is a multi-center, randomized, double-masked, placebo-controlled, Phase 2b trial evaluating the safety and efficacy of NCX 4251 (fluticasone propionate nanocrystal) Ophthalmic Suspension 0.1% QD for the treatment of acute exacerbations of ble...
https://clinicaltrials.gov/ct2/show/NCT04784091
Dec 2nd, 2022 - This Phase 3 study is a randomized, controlled, multicenter, double-masked, parallel trial to compare the safety and efficacy of TP-03 to vehicle control for the treatment of Demodex blepharitis. The primary objective of the study is to assess the...
https://clinicaltrials.gov/ct2/show/NCT05629390
Nov 29th, 2022 - The main study is designed to demonstrate the superiority of 0.25%TP-03 to vehicle for the treatment of Demodex blepharitis in China. The vehicle of TP-03 was selected as the control since there are no approved pharmaceutical treatments for Demode...
https://clinicaltrials.gov/ct2/show/NCT05608980
Nov 8th, 2022 - This is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.
News 39 results
https://www.mdedge.com/dermatology/article/259630/hair-nails/dupilumab-therapeutic-approach-alopecia-universalis
Michael J. Visconti, DO, Adam Richardson, DO et. al.
Nov 21st, 2022 - To the Editor: Atopic diseases, specifically atopic dermatitis (AD) and alopecia areata (AA), are at the forefront of a new era in dermatology involving molecular-directed therapy. Dupilumab is one specific example, having received US Food and Dru.
https://www.mdedge.com/atopic-dermatitis-challenge-center/article/259563/atopic-dermatitis/red-swollen-eyelids
Nov 18th, 2022 - This patient's symptoms are consistent with a diagnosis of blepharitis. Blepharitis is an inflammatory disorder of the eyelids that is frequently associated with bacterial colonization of the eyelid.
https://www.medscape.com/viewarticle/982594
Oct 17th, 2022 - Although ocular monkeypox is rare, it can be a condition that threatens a person's sight, a Centers for Disease Control and Prevention (CDC) report says. The report details five people with monkeypox who developed eye complications from July throu...
https://www.onclive.com/view/ocular-toxicity-with-belantamab-mafodotin-is-not-influenced-by-baseline-ocular-conditions-in-r-r-myeloma
Aug 27th, 2022 - Baseline ocular conditions not related to the cornea have little effect on treatment-emergent adverse effects (TEAEs) that may arise with belantamab mafodotin-blmf (Blenrep) in patients with relapsed/refractory multiple myeloma, according to a pos...
https://www.mdedge.com/dermatology/article/250216/atopic-dermatitis/prevalence-and-risk-factors-ocular-surface-disease
Dec 25th, 2021 - Key clinical point: Ocular surface diseases (OSD), particularly conjunctivitis, are prevalent among patients with atopic dermatitis (AD), with the prevalence increasing with AD severity and childhood onset of AD. Major finding: Of all OSDs, lifeti.